Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-17±³À°ÀÏÀÚ : 2022-06-17
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È»ó °ÀÇ) ¹× ¼¿ï·Ôµ¥È£ÅÚ 2, 3Ãþ 5°³·ë
±³À°ÁÖÁ¦ :
(¿Â∙¿ÀÇÁ¶óÀÎ º´Çà) Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486
À̸ÞÀÏ :
cancer2@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 23 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í 1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 10¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 10¸¸¿ø 2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 15¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 20¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-17 Room A 08:40~09:05 Unique needs and concerns of childhood cancer survivors Yasushi Ishida(Ehime Prefectural Central Hospital, Japan)
±³À°½Ã°£ 06-17 Room A 09:05~09:30 Building a cancer survivorship program Miyako Tsuchiya(National Cancer Center, Japan)
±³À°½Ã°£ 06-17 Room A 09:30~09:55 Integrating psycho-oncology to improve mental health for cancer survivors Á¤¼®ÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-17 Room A 09:55~10:20 The effect of exercise on the QoL and survival in cancer survivors Àü¿ë°ü(¿¬¼¼´ë)
±³À°½Ã°£ 06-17 Room B 08:40~09:05 EGFR-targeted therapy ÇÑÁö¿¬(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06-17 Room B 09:05~09:30 HER2-targeted therapy Shaheenah Dawood(Mohammed Bin Rashid University of Medicine and Health Sciences, UAE)
±³À°½Ã°£ 06-17 Room B 09:30~09:55 Anti-angiogenetic therapy Masafumi Ikeda(National Cancer Center Hospital East, Japan)
±³À°½Ã°£ 06-17 Room B 09:55~10:20 RAS/RAF/MEK inhibitor ÀÌÁö¿¬(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-17 Room D 08:40~09:05 What we have learned on oligometastasis David Anthony Palma(London Health Science Center, Canada)
±³À°½Ã°£ 06-17 Room D 09:05~09:21 Korean radiation oncologists ÀÓäȫ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-17 Room D 09:21~09:37 Korean medical oncologists ÀÌ´ëÈ£(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-17 Room D 09:37~09:53 Management of oligometastasis from colorectal cancer ÀÌÁ¾ÈÆ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-17 Room D 09:53~10:20 Locally aggressive RT for oligometastasis: SBRT & Hypo-Fx Hak Choy(University of Texas Southwestern Medical Center, USA)
ÈÞ½Ä 06-17 10:20~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 06-17 Room A 10:40~11:20 Pancreas Cancer – molecular diagnostics and therapeutics Jeffrey A. Drebin(Memorial Sloan Kettering Cancer Center, USA)
±³À°½Ã°£ 06-17 Room A 11:20~12:00 Clonal evolution in normal tissues Seishi Ogawa(Kyoto University Graduate School of Medicine, Japan)
±³À°½Ã°£ 06-17 Room D 11:20~11:40 Metastatic pancreatic cance ¹ÌÁ¤()
½Ä»ç 06-17 12:00~12:30 ½Ä»ç ()
±³À°½Ã°£ 06-17 Room A 12:30~13:10 Recent updates of CDK4/6i data ¹ÌÁ¤()
±³À°½Ã°£ 06-17 Room D 12:30~13:10 Today & Tomorrow of EGFRm NSCLC: From early to advanced stage ÀÓ¼±¹Î(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 06-17 13:10~13:25 ÈÞ½Ä ()
±³À°½Ã°£ 06-17 Room A 13:25~13:40 Future leadership of AOS - Korea ±è¿È«(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-17 Room A 13:40~13:55 Future leadership of AOS - India Sanjeev Misra(King George)
±³À°½Ã°£ 06-17 Room A 13:55~14:10 Future leadership of AOS - China Ying Wang(China Anti-Cancer Association, China)
±³À°½Ã°£ 06-17 Room A 14:10~14:25 Future leadership of AOS - Japan Kazuhiro Yoshida(Gifu University, Graduate School of Medicine, Japan)
Åä·Ð 06-17 Room A 14:25~15:05 Panel Discussion ()
±³À°½Ã°£ 06-17 Room B 13:25~13:50 Immunologic resistance mechanisms of cancer immunotherapy ½ÅÀÇö(KAIST)
±³À°½Ã°£ 06-17 Room B 13:50~14:15 Immunotherapy resistance and its overcoming strategy in lung cancer À̼¼ÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-17 Room B 14:15~14:40 Immunotherapy resistance and its overcoming strategy in gastric cancer Narikazu Boku(University of Tokyo, Japan)
±³À°½Ã°£ 06-17 Room B 14:40~15:05 Immunotherapy combination therapy for immune checkpoint inhibitor-resistant cancer Hussein A. Tawbi(MD Anderson Cancer Center, USA)
±³À°½Ã°£ 06-17 Room D 13:25~13:50 Landscape and function of multiple mutations within individual oncogenes. Keisuke Kataoka(Keio University School of Medicine, Japan)
±³À°½Ã°£ 06-17 Room D 13:50~14:15 Extrachromosomal DNA in multiple cancers ±èÈÆ(¼º±Õ°ü´ë ¾à´ë)
±³À°½Ã°£ 06-17 Room D 14:15~14:40 Profiling of circulating tumor DNA Iain Tan(Genome Institute of Singapore, Singapore)
±³À°½Ã°£ 06-17 Room D 14:40~15:05 Functional mutation pairs in cancer genomes ±èŹÎ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06-17 Room E 13:25~13:50 Molecular biology of CNS metastases °ûÈ£½Å(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 06-17 Room E 13:50~14:15 Targeted therapy for advanced cancer with CNS metastases ±èÇý·Ã(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-17 Room E 14:15~14:40 Local treatment for CNS metastases in the targeted therapy era ±è¿µÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-17 Room E 14:40~15:05 RANO response criteria for brain and leptomeningeal metastases ÃÖ½ÂÈ«(¼¿ïÀÇ´ë)
ÈÞ½Ä 06-17 15:05~15:25 ÈÞ½Ä ()
±³À°½Ã°£ 06-17 Room A 15:25~15:50 Lung cancer screening Pan-Chyr Yang(National Taiwan University, Taiwan)
±³À°½Ã°£ 06-17 Room A 15:50~16:15 Surgical treatment Hisao Asamura(Keio University School of Medicine, Japan)
±³À°½Ã°£ 06-17 Room A 16:15~16:40 Radiation treatment Zhengfei Zhu(Fudan University Shanghai Cancer Center, China)
±³À°½Ã°£ 06-17 Room A 16:40~17:05 Medical treatment ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-17 Room B 15:25~15:55 Targeting DNA damage pathway in advanced cancers David Tan(National University of Singapore, Singapore)
±³À°½Ã°£ 06-17 Room B 15:55~16:25 Mechanisms of resistance to PARP inhibitors in advanced cancers ÀÌ°æÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-17 Room B 16:25~16:55 PARP inhibition in future Nicola Jane Curtin(Newcastle University Centre for Cancer, UK)
Åä·Ð 06-17 Room B 16:55~17:05 Q&A Discussion ()
±³À°½Ã°£ 06-17 Room C 15:25~17:05 ´ëÇѾÏÇÐȸ°¡ ÁÖÃàÀÌ µÇ´Â Cancer Guideline ±¸Ãà ¹ÌÁ¤()
±³À°½Ã°£ 06-17 Room D 15:25~15:50 Evolution of cervical cancer treatment with the emergence of immune checkpoint inhibitors Masahiro Kagabu(Iwate Medical University, Japan)
±³À°½Ã°£ 06-17 Room D 15:50~16:15 2020 WHO classification of cervical adenocarcinoma ÀÌö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 06-17 Room D 16:15~16:40 Recent advance of radiotherapy for cervical cancer Sezin Yuce Sari(Hacettepe University Medical School, Turkey)
±³À°½Ã°£ 06-17 Room D 16:40~17:05 DNA vaccine as a novel treatment for cervical cancer in future ÃÖÀ±Áø(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 06-17 Room E 15:25~15:50 Past, present, future of palliative care in Japan Yusuke Hiratsuka(Takeda General Hospital, Japan)
±³À°½Ã°£ 06-17 Room E 15:50~16:15 Past, present, future of palliative care in Taiwan Shao-Yi Cheng(College of Medicine, National Taiwan University, Taiwan)
±³À°½Ã°£ 06-17 Room E 16:15~16:40 Recent efforts to expand horizons of palliative care in Korea ±èÀ¯Á¤(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-17 Room E 16:40~17:05 Life-sustaining treatment states in Korean cancer patients after enforcement of act on decisions on life-sustaining treatment ±ÇÁ¤Çý(¼¼Á¾Ãæ³²´ëº´¿ø)